A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with β-thalassemia major

European Journal of Haematology

Volumn 75, Issue 3, 2005, Pages 241-247

  Mavrogeni, Sophie I ^a,d   Markussis, Vyron ^a   Kaklamanis, Loukas ^a   Tsiapras, Dimitrios ^a   Paraskevaidis, Ioannis ^a   Karavolias, George ^a   Karagiorga, Markisia ^b   Douskou, Marouso ^c   Cokkinos, Dennis V ^a   Kremastinos, Dimitrios T ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^c BIOIATRIKI HEALTHCARE GROUP   (Greece)

^d NONE   (Greece)

Author keywords

Heart biopsy; Iron; Magnetic resonance imaging; Thalassemia

Indexed keywords

ADULT; ARTICLE; BETA THALASSEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; FERRITIN BLOOD LEVEL; HEART FAILURE; HEART MUSCLE BIOPSY; HUMAN; INTERMETHOD COMPARISON; IRON OVERLOAD; IRON THERAPY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAXATION TIME; STATISTICAL ANALYSIS; TECHNIQUE; THALASSEMIA MAJOR;

ADULT; BETA-THALASSEMIA; BIOPSY; FEMALE; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM;

EID: 23844446755     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00474.x     Document Type: Article

References (34)

1. MODELL B, KHAN M, DARLISON M. Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet 2000;355:2051-2052.
2. SANKUL D, THAKERNGPAL K, PARCHAREE P. Cardiac pathology in 76 thalassemic patients. Birth Defects 1988;23:177-181.
3. OHENE-FREMPONG K, SCHWARTZ E. Clinical features of thalassemia. Pediatr Clin North Am 1980;27:403-411.
4. CHRYSOHOOU C, PANAGIOTAKOS D, BARBETSEAS Y, BRILLI S, LAMBROU S, KARAGIORGA M, LADIS VA, PITSAVOS C, STEFANADIS C. Echocardiographic and electrocardiographic prognostic factors of heart failure in young patients with β-thalassemia major: a 10-year (1995-2004) follow-up. Int J Hematol 2004;80:336-340.
5. WACKER P, HALPERIN DS, BALMER-RUEDIN D, OBERHANSLI I, WYSS M. Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major. Chest 1993;103:1276-1278.
6. HENRY WL, NIENHUIS AW, WIENER M, MILLER DR, CANALE VC, PIOMELLI S. Echocardiographic abnormalities in patients with transfusion-dependent anemia and secondary myocardial iron deposition. Am J Med 1978;64:547-555.
7. OLSON LJ, EDWARDS WD, MCCALL JT, ILSTRUP DM, GERSH BJ. Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. J Am Coll Cardiol 1987;10:1239-1243.
8. BUJA LM, ROBERTS WC. Iron in the heart: etiology and clinical significance. Am J Med 1971;51:209-221.
9. JACOBS A. The pathology of iron overload. In: JACOBS A, WORWOOD M, eds. Iron in Biochemistry and Medicine, II. New York: Academic Press, 1980:439-452.
10. ANDERSON LJ, HOLDEN S, DAVIS B et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron deposition. Eur Heart J 2001;22:2171-2179.
11. JACOBS A, MILLER F, WORWOOD M, BEAMISH RW, WARDROP CA. Ferritin in the serum of normal subjects with iron deficiency and iron overload. Br Med J 1972;4:206-208.
12. CROSBY WH. Serum ferritin fails to indicate hemochromatosis: nothing gold can stay. N Engl J Med 1976;294:333-334.
13. BARRY M, SHERLOCK S. Measurement of liver iron concentration in liver biopsy specimens. Lancet 1971;1:100-103.
14. MAVROGENI S, MARIS T, GOULIAMOS T, VLAHOS L, KREMASTINOS DT. Myocardial Iron deposition in b-thalassemia studied by magnetic resonance imaging. Int J Cardiac Imaging 1998;14:117-122.
15. JOHNSTON DL, RICE L, VICK GW, HEDRICK TD, ROKEY R. Assessment of tissue iron overload by nuclear magnetic resonance imaging. Am J Med 1989;87:40-47.
16. JENSEN PD, JENSEN FT, CHRISTENSEN T, EISKJAER H, BAANDRUP U, NIELSEN JL. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood 2003;101:4632-4639.
17. BRITTENHAM GM, BADMAN DG. Noninvasive measurement of iron: report of an NIDDK workshop. Blood 2003;101:15-19.
18. LIU P, HENKELMAN M, JOSHI J et al. Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia-cardiac iron overload model. Can J Cardiol 1996;12:155-164.
19. MCKEE PA, CASTELLI WP, MCNAMARA PM, KANNEL WB. The natural history of congestive heart failure, the Framingham Study. N Engl J Med 1971;285:1441-1446.
20. OLIVIERI NF, NATHAN DG, MACMILLAN JH, WAYNE AS, LIU PP, MCGEE A, MARTIN M, KOREN G, COHEN AR. Survival in medically treated patients with homozygous b-thalassemia. N Engl J Med 1994;331:574-578.
21. CAVES P, COLTART J, BILLINGHAM MB, RIDER A, STINSON E. Transvenous endomyocardial biopsy-application of a method for diagnosing heart disease. Postgrad Med J 1975;51:286-290.
22. BAROSI G, ARBUSTINI E, GAVAZZI A, GRASSO M, PUCCI A. Myocardial iron grading by endomyoacardial biopsy. A clinico-pathologic study on iron overloaded patients. Eur J Haematol 1989;42:382-388.
23. GUANGQIN MA, HALL WJ. Confidence bands for receiver operating characteristic curve. Med Decis Making 1993;13:191-197.
24. STARK DD, MOSELEY ME, BACON BR, MOSS AA, GOLDBERG HI, BASS NM, JAMES TL. Magnetic resonance imaging and spectroscopy of hepatic iron overload. Radiology 1985;154:137-142.
25. GOMORI JM, HOREV G, TAMARY H et al. Hepatic iron overload: quantitative MR imaging. Radiology 1991;179:367-369.
26. PAPAKONSTANTINOU O, MARIS T, KOSTARIDOU V et al. Assessment of liver iron overload by T2-quantitative magnetic resonance imaging. Correlation of T2-QMRI measurements with serum ferritin concentration and histologic grading of siderosis. Magn Res Imaging 1995;13:967-977.
27. GANDON Y, OLIVIE D, GUYADER D, AUBE C, OBERTI F, SEBILLE V, DEUGNIER Y. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004;363:357-362.
28. CUTLER GJ, ISNER JM, BRACEY AW, HUFNAGEL CA, CONRAD PW, ROBERTS WC, KERWIN DM, WEINTRAUB AM. Hemochromatosis heart disease: an unemphasized cause of potentially reversible restrictive cardiomyopathy. Am J Med 1980;69:923-928.
29. ARNETT EN, NIENHUIS AW, HENRY WL, FERRANS VJ, REDWOOD DR, ROBERTS WC, ROBERTS WC. Massive myochondrial hemosiderosis: a structure function conference at the National Heart and Lung Institute. Am Heart J 1975;90:777-787.
30. SCHELLHAMMER PF, ENGLE MA, HAGSTROM JWC. Histochemical studies of the myocardium and conduction system in acquired iron-storage disease. Circulation 1967;35:631-39.
31. STARK DD. Hepatic iron overload: paramagnetic pathology. Radiology 1991;179:333-305.
32. HARDY PA, HENKELMAN RM. Transverse relaxation rate enhancement caused by magnetic particulates. Magn Reson Imaging 1989;7:265-275.
33. VYMAZAL J, BROOKS RA, ZAK O, MCRILL C, SHEN C, DI CHIRO G. T1 and T2 of ferritin at different field strengths: Effect on MRI. Magn Res Med 1992;27:368-374.
34. MAVROGENI S, GOTSIS E, MARKUSSIS V, TSEKOS N, POLITIS C, VRETOU E, KERMASTINOS D. T2 relaxation time study of iron overload in b-thalassemia. MAGMA 1998;6:7-12.